[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"updates-archive-2026-04-29-3":3},{"date":4,"filings":5,"has_more":620,"limit":621,"page":622,"total_count":623},"2026-04-29",[6,14,21,28,35,42,50,56,61,68,73,79,86,93,98,103,110,115,120,127,134,139,146,151,157,162,167,174,180,185,190,195,202,209,214,221,226,231,238,245,250,255,262,267,272,279,284,291,296,301,308,313,320,325,331,336,343,348,353,360,366,372,378,385,391,398,404,411,417,423,430,436,441,448,453,460,467,474,481,488,494,499,504,511,517,524,530,535,541,548,555,561,566,572,578,585,592,599,606,613],{"company_name":7,"filing_date":8,"filing_source":9,"headline":10,"id":11,"stock_code":12,"summary_text":13},"RPG Life Sciences Ltd","2026-04-29T21:01:40.954000","BSE","Profit Dips 37% on One-Off Charges, Declares ₹24 Dividend","69f224ac5236ec998939cb68","RPGLIFE","• \u003Cb>FY26 Results:\u003C\u002Fb> Net Profit (PAT) fell sharply by 37.1% to ₹11,517 Lakhs, despite an 8.3% rise in Revenue. The decline was driven by significant one-off charges and lower exceptional income.\n• \u003Cb>Dividend Declared:\u003C\u002Fb> The Board has recommended a final dividend of ₹24 per equity share (300% of face value), subject to shareholder approval.\n• \u003Cb>Major Restructuring:\u003C\u002Fb> The company is proceeding with the transfer of its API (Active Pharmaceutical Ingredients) division into a new wholly-owned subsidiary.\n• \u003Cb>Board Appointment:\u003C\u002Fb> Dr. Pratit Samdani has been appointed as an Additional Non-Executive Independent Director for a five-year term.",{"company_name":15,"filing_date":16,"filing_source":9,"headline":17,"id":18,"stock_code":19,"summary_text":20},"Systematix Corporate Services Ltd","2026-04-29T21:01:40.942000","Reports Sharp Profit Decline & Q4 Loss, Proposes Dividend","69f224b3c9cbead9b3c54bcd","526506","*   **Financials**: Reported a consolidated net loss of ₹1,179.17 Lakhs for Q4 FY26, a sharp reversal from a profit of ₹329.85 Lakhs in Q4 FY25. Full-year profit (PAT) fell to ₹1,385.16 Lakhs from ₹4,576.13 Lakhs in FY25.\n*   **Dividend**: The Board recommended a final dividend of ₹0.10 per share (10% of face value) for FY26, subject to shareholder approval.\n*   **Segment Performance**: Two key segments, 'Financing' and 'Transactional Services', swung to significant losses, driving the overall poor performance. The 'Financing' segment's revenue dropped by 59%.\n*   **Red Flag**: A subsidiary, Systematix Commodities Services Pvt. Ltd., faces potential registration cancellation by SEBI. The company's appeal is currently pending before the Securities Appellate Tribunal (SAT).\n*   **Corporate Actions**: The Board approved the appointment of Mr. Pradeep Gotecha as the new Internal Auditor and plans to strike off an inoperative subsidiary LLP.",{"company_name":22,"filing_date":23,"filing_source":9,"headline":24,"id":25,"stock_code":26,"summary_text":27},"Indegene Ltd","2026-04-29T21:01:40.933000","FY26 Results: Revenue Jumps 24%, Dividend Declared Amidst Legal Headwinds","69f224b0ecaa861d9491e9af","INDGN","*   \u003Cb>FY26 Revenue Growth:\u003C\u002Fb> Revenue from operations grew 23.6% YoY to ₹35,105 million, driven by strong performance in the Enterprise Commercial Solutions segment (+27.2% YoY).\n*   \u003Cb>Dividend Declared:\u003C\u002Fb> The Board has recommended a final dividend of ₹2.25 per equity share for the financial year ended March 31, 2026.\n*   \u003Cb>Aggressive M&A:\u003C\u002Fb> The company spent over ₹10 billion on acquisitions in FY26, including the major purchase of BioPharm Parent Holdings for ₹8,821 million.\n*   \u003Cb>Legal & Tax Issues:\u003C\u002Fb> A provision of ₹203 million was made for a US class-action lawsuit settlement. The company also disclosed a significant contingent liability of ₹1,114 million related to a transfer pricing dispute.\n*   \u003Cb>Profitability Note:\u003C\u002Fb> Diluted EPS for FY26 stood at ₹16.62, a slight decrease from ₹17.02 in FY25, impacted by the exceptional item for the lawsuit.",{"company_name":29,"filing_date":30,"filing_source":9,"headline":31,"id":32,"stock_code":33,"summary_text":34},"Shakti Press Ltd","2026-04-29T21:01:40.723000","Announces Rights Issue with 8x Dilution & Promoter Non-Participation","69f224eff35e30561cff68a6","526841","*   Announced a Rights Issue of 7 shares for every 1 share held, leading to an 8-fold equity dilution.\n*   \u003Cb>[RED FLAG]\u003C\u002Fb> Promoters will NOT subscribe to their rights entitlement, signaling a lack of confidence.\n*   \u003Cb>[RED FLAG]\u003C\u002Fb> FY25 Profit After Tax plummeted 86% to ₹6.70 Lakhs, while total borrowings surged 162%.\n*   \u003Cb>[RED FLAG]\u003C\u002Fb> Outstanding convertible warrants create a risk of further significant equity dilution in the future.\n*   The issue price is set at ₹20 per share to raise up to ₹4928.28 Lakhs, primarily for working capital.",{"company_name":36,"filing_date":37,"filing_source":9,"headline":38,"id":39,"stock_code":40,"summary_text":41},"Regency Fincorp Ltd","2026-04-29T21:01:40.717000","Board Approves ₹25 Crore Fundraise & Branch Consolidation","69f224980c6b4fb98a91ed34","540175","• Approved raising up to **₹25 Crore** through a private placement of Secured, Listed, Non-Convertible Debentures (NCDs).\n• The NCDs have an unusually short maturity date of **June 23, 2026** (less than 2 months), suggesting an urgent need for short-term liquidity.\n• The debentures will offer a high coupon rate of **14% per annum** and will be secured by a 1.25x asset cover.\n• The company will close its Barnala branch and merge its operations with the Jagraon branch, effective July 29, 2026.",{"company_name":43,"filing_date":44,"filing_source":45,"headline":46,"id":47,"stock_code":48,"summary_text":49},"Flexituff Ventures International Limited","2026-04-29T21:01:39.859000","NSE","Welcomes New Director to the Board","69f22490bf8f716f13ff6cf5","FLEXITUFF","*   The Board has appointed **Mrs. Gudiya Yadav** as an Additional **Non-Executive Non-Independent** Women Director, effective **April 29th, 2026**.\n*   Mrs. Yadav brings \"practical experience in operational supervision\" and is expected to assist in production-related activities.\n*   The appointment is for a term of 24 months and is subject to the approval of shareholders at a future general meeting.\n*   The company confirmed she is not debarred from holding the office of Director by any SEBI order or other authority.",{"company_name":51,"filing_date":52,"filing_source":45,"headline":53,"id":54,"stock_code":26,"summary_text":55},"Indegene Limited","2026-04-29T21:01:39.778000","Board Proposes a 112.5% Final Dividend","69f22482abd16353d2ff6fa8","• The Board of Directors has recommended a final dividend of 112.5% for the financial year ended March 31, 2026.\n• This dividend is subject to the approval of shareholders at the forthcoming Annual General Meeting (AGM).\n• The record date and payment date for the dividend will be determined and communicated at a later date.",{"company_name":43,"filing_date":57,"filing_source":45,"headline":58,"id":59,"stock_code":48,"summary_text":60},"2026-04-29T21:01:39.677000","New Director Appointed to the Board","69f2248a58d874434539cef0","*   The company has appointed Mrs. Gudiya Yadav as a Non-Executive Non-Independent Director, effective April 29, 2026.\n*   Mrs. Yadav is 24 years old with stated \"practical experience in operational supervision.\"\n*   \u003Cb>Key Red Flag:\u003C\u002Fb> The appointment is considered highly unusual for a board-level position due to the director's age and vague experience. Her role is described as assisting in production, which is more operational than a typical board oversight function, raising potential governance questions.",{"company_name":62,"filing_date":63,"filing_source":45,"headline":64,"id":65,"stock_code":66,"summary_text":67},"Diensten Tech Limited","2026-04-29T21:01:39.493000","To Raise ₹4.58 Crore via Preferential Issue of Warrants","69f2249ea157653c6639d289","DTL","*   The company seeks to raise up to \u003Cb>₹4.58 crore\u003C\u002Fb> by issuing \u003Cb>3,98,800 convertible warrants\u003C\u002Fb> on a preferential basis at \u003Cb>₹115 per warrant\u003C\u002Fb>.\n*   Proceeds are intended for \u003Cb>repayment of loans (₹3.44 Cr)\u003C\u002Fb>, funding potential \u003Cb>acquisitions\u003C\u002Fb>, and general corporate purposes.\n*   \u003Cb>Promoters & Promoter Group\u003C\u002Fb> are the primary allottees, set to receive \u003Cb>~91.3%\u003C\u002Fb> of the issue. This will increase their shareholding from 70.85% to \u003Cb>71.79%\u003C\u002Fb>.\n*   The issue will lead to an equity dilution of approximately \u003Cb>4.8%\u003C\u002Fb> for existing shareholders upon full conversion of the warrants.",{"company_name":51,"filing_date":69,"filing_source":45,"headline":70,"id":71,"stock_code":26,"summary_text":72},"2026-04-29T21:01:39.419000","Acquisitions Drive 24% Revenue Growth, But Profits Dip","69f224d7f43b112c8d91e5a7","*   Full-year revenue grew 23.6% to ₹35,105 million, but Profit After Tax (PAT) slightly declined to ₹4,011 million due to higher expenses and a one-off litigation provision.\n*   The Board has recommended a final dividend of ₹2.25 per equity share for the financial year 2026, subject to shareholder approval.\n*   The company pursued an aggressive acquisition strategy, spending over ₹10 billion on acquiring BioPharm, Warn & Co, and the Cake Group to bolster its commercial solutions segment.\n*   Key risks highlighted include a ₹203 million provision for a US lawsuit and a significant contingent liability of ₹1,114 million related to a draft transfer pricing order.",{"company_name":74,"filing_date":75,"filing_source":45,"headline":76,"id":77,"stock_code":12,"summary_text":78},"RPG Life Sciences Limited","2026-04-29T21:01:39.208000","Recommends 300% Dividend & Announces Major API Business Spin-off","69f224c0ec7f5de862c54835","*   FY26 Net Profit (PAT) fell 37% to ₹115 Cr, primarily due to a large one-off gain in the previous year; core operational profit remained flat.\n*   The Board recommended a final dividend of **₹24 per share**, a **300%** payout on the face value of ₹8.\n*   Announced a major restructuring to transfer its API (Active Pharmaceutical Ingredient) division into a new wholly-owned subsidiary.\n*   Booked an impairment charge of ₹9.16 Cr for writing off an 'Intangible Asset Under Development', indicating a failed project.\n*   Appointed Dr. Pratit Samdani, a respected physician, as a new Non-Executive Independent Director for a 5-year term.",{"company_name":80,"filing_date":81,"filing_source":45,"headline":82,"id":83,"stock_code":84,"summary_text":85},"Acme Solar Holdings Limited","2026-04-29T21:01:39.155000","Major Boost to Battery Storage Project","69f2248c890e096a6fc54efb","ACMESOLAR","*   Successfully commissioned an additional **35.714 MW \u002F 160.512 MWh** for its Battery Energy Storage System (BESS) project in Bikaner, Rajasthan.\n*   The new capacity is scheduled for commercial operation starting **May 01, 2026**, which is expected to contribute to future revenue.\n*   This brings the project's total commissioned capacity to **175.223 MW \u002F 787.387 MWh**.\n*   The filing notes this as a **material positive development**, highlighting the company's project execution capabilities and ESG contribution.",{"company_name":87,"filing_date":88,"filing_source":9,"headline":89,"id":90,"stock_code":91,"summary_text":92},"Centenial Surgical Suture Ltd","2026-04-29T20:51:40.766000","Clears the Air: Not a 'Large Corporate' & Reports Zero Debt","69f2223a0c6b4fb98a91ed26","531380","*   Centenial Surgical has filed a declaration stating it is **not** a \"Large Corporate\" under SEBI's applicability criteria.\n*   The company reported **NIL outstanding borrowings** as of the most recent March 31st, indicating a debt-free status.\n*   This disclosure was a mandatory compliance filing made to the BSE Limited.\n*   The lack of rated debt and borrowings suggests a very low financial risk profile and a strong balance sheet.",{"company_name":7,"filing_date":94,"filing_source":9,"headline":95,"id":96,"stock_code":12,"summary_text":97},"2026-04-29T20:51:40.710000","Recommends ₹24 Dividend, Plans API Business Spinoff","69f22250a157653c6639d27b","*   The Board has recommended a final dividend of **₹24 per share** (300% on face value) for FY26, subject to shareholder approval.\n*   Revenue from Operations grew **8.3%** year-over-year to ₹70,752 Lakhs.\n*   Net Profit After Tax declined to ₹11,517 Lakhs. This was primarily driven by one-off exceptional charges in FY26 and a large exceptional gain in the previous year; **core operational profitability remained stable**.\n*   The company is proceeding with a plan to transfer its **API (Active Pharmaceutical Ingredient) division** into a new, wholly-owned subsidiary.",{"company_name":22,"filing_date":99,"filing_source":9,"headline":100,"id":101,"stock_code":26,"summary_text":102},"2026-04-29T20:51:40.706000","FY26 Results: Revenue Soars 24%, Profit Dips on One-Offs; Dividend Hiked","69f2226becaa861d9491e9a4","- Revenue for FY26 grew 23.6% YoY to ₹35,105 Mn, crossing the ₹3,500 crore mark.\n- Reported Profit After Tax (PAT) declined 1.4% to ₹4,011 Mn, impacted by one-off items including MTM losses (₹398 Mn) and a lawsuit provision (₹203 Mn). Adjusted PAT stood at ₹4,583 Mn.\n- The Board recommended a final dividend of ₹2.25 per share, a 12.5% increase over the previous year.\n- Completed the acquisition of BioPharm Parent Holding, Inc., which is now integrated into operations and contributing to revenue.\n- Key operational metrics showed strength, with clients contributing over $1 Mn in revenue growing by 29.3% and Net Revenue Retention increasing to 105.8%.\n- Management expressed confidence for FY27, highlighting a strong pipeline and a strategic focus on GenAI-led initiatives to drive future growth.",{"company_name":104,"filing_date":105,"filing_source":45,"headline":106,"id":107,"stock_code":108,"summary_text":109},"Adani Total Gas Limited","2026-04-29T20:51:39.434000","Shareholder Alert: Update KYC & Claim Dividends","69f2224aec7f5de862c5482c","ATGL","*   The company has issued a notice urging shareholders to update their KYC details, including PAN, bank information, and contact details.\n*   Failure to update KYC may result in the freezing of share accounts (folios).\n*   Shareholders are reminded to claim any unclaimed dividends to prevent them (and corresponding shares) from being transferred to the Investor Education and Protection Fund (IEPF).\n*   This action is part of SEBI's \"Second 100 Days Campaign - 'Saksham Niveshak'\" for investor awareness.",{"company_name":51,"filing_date":111,"filing_source":45,"headline":112,"id":113,"stock_code":26,"summary_text":114},"2026-04-29T20:51:39.186000","Indegene's Revenue Soars 24% in FY26, Profit Dips on One-Offs","69f22251f35e30561cff689c","*   Revenue from Operations grew 23.6% YoY to ₹35,105 M, a significant re-acceleration from 9.6% growth in the previous year.\n*   Reported Profit After Tax (PAT) declined 1.4% to ₹4,011 M due to one-off expenses, MTM losses, and a ₹203 Mn lawsuit provision. Adjusted PAT stood at ₹4,583 M.\n*   The Board recommended a final dividend of ₹2.25 per share, a 12.5% increase over the previous year.\n*   The company saw strong client momentum, with the number of clients contributing over $1 million in revenue growing by 29.3% to 53.\n*   Growth was led by the Enterprise Commercial Solutions segment, which grew 37.7% YoY, driven by GenAI initiatives and acquisition synergies.",{"company_name":74,"filing_date":116,"filing_source":45,"headline":117,"id":118,"stock_code":12,"summary_text":119},"2026-04-29T20:51:39.169000","Declares 300% Dividend; PAT Falls 37% on One-Offs","69f222a6bf8f716f13ff6ceb","*   \u003Cb>Dividend Declared:\u003C\u002Fb> The Board has recommended a final dividend of ₹24 per share (a 300% payout) for the financial year 2025-26, subject to shareholder approval.\n*   \u003Cb>Profit Analysis:\u003C\u002Fb> Reported Profit After Tax (PAT) dropped 37.15% to ₹11,517 Lakhs. This was driven by large, non-recurring exceptional items (like new labor code impact & asset impairment). Core profit before exceptional items remained stable year-over-year.\n*   \u003Cb>Strategic Restructuring:\u003C\u002Fb> The company is transferring its API (Active Pharmaceutical Ingredients) business to a new wholly-owned subsidiary, RPG Active Pharma Limited, to create a focused business vertical.\n*   \u003Cb>Board Appointment:\u003C\u002Fb> Dr. Pratit Samdani, a respected physician, has been appointed as a new Non-Executive Independent Director for a 5-year term.",{"company_name":121,"filing_date":122,"filing_source":9,"headline":123,"id":124,"stock_code":125,"summary_text":126},"TANFAC Industries Ltd","2026-04-29T20:46:41.718000","Signs Long-Term Supply Agreement with Blue Star Ltd!","69f22158c9cbead9b3c54bbd","506854","*   Entered into a Long-Term Agreement with Blue Star Limited for the supply of a fluorinated product.\n*   This marks the second major long-term contract secured in a short period, indicating growing customer confidence and revenue stability.\n*   The supply under this new contract is set to commence from 1st January 2027.\n*   Management highlights that the deal enhances earnings predictability and reinforces the company's position as a reliable supplier in the global fluorinated product market.",{"company_name":128,"filing_date":129,"filing_source":9,"headline":130,"id":131,"stock_code":132,"summary_text":133},"Insolation Energy Ltd","2026-04-29T20:46:41.594000","Confirms It's Not a 'Large Corporate' Under SEBI Rules","69f22132f35e30561cff6896","543620","*   The company has filed its annual confirmation stating it does **not** qualify as a \"Large Corporate\" under SEBI's framework as of March 31, 2026.\n*   This is because its outstanding borrowing of ₹37.14 Crore is below the ₹100 Crore threshold.\n*   Additionally, its highest credit rating is 'CARE BBB+', which is below the required 'AA' rating.\n*   As a result, the company is not mandated to raise a minimum of 25% of its incremental long-term borrowings via debt securities (bonds).",{"company_name":15,"filing_date":135,"filing_source":9,"headline":136,"id":137,"stock_code":19,"summary_text":138},"2026-04-29T20:46:41.545000","Declares Dividend but Faces Profit Drop and Regulatory Headwinds","69f22147bf8f716f13ff6ce6","*   \u003Cb>Dividend Declared:\u003C\u002Fb> The Board recommended a final dividend of ₹0.10 per share (10%) for FY26, subject to shareholder approval.\n*   \u003Cb>Profitability Slumps:\u003C\u002Fb> Consolidated Profit Before Tax for FY26 fell sharply to ₹2,270.87 Lakhs from ₹5,709.15 Lakhs in FY25. The company reported a consolidated loss before tax of ₹(1,200.34) Lakhs for Q4 FY26.\n*   \u003Cb>Mixed Segment Performance:\u003C\u002Fb> While the Merchant Banking segment grew revenue by 13.85%, the Financing and Equity\u002FCommodity segments saw steep revenue declines of 59.15% and 28.58% respectively.\n*   \u003Cb>Major Regulatory Risk:\u003C\u002Fb> A key subsidiary (SCSPL) faces a pending legal matter where its registration was cancelled by SEBI. Although currently stayed by the Securities Appellate Tribunal (SAT), the issue poses a significant risk.\n*   \u003Cb>Corporate Actions:\u003C\u002Fb> The Board approved the appointment of a new Internal Auditor for FY 2026-27 and will file to strike off an inoperative subsidiary LLP.",{"company_name":140,"filing_date":141,"filing_source":9,"headline":142,"id":143,"stock_code":144,"summary_text":145},"New Delhi Television Ltd","2026-04-29T20:46:41.428000","NDTV Secures Stay on Rs. 420.36 Crore Tax Demand","69f22133ecaa861d9491e99e","NDTV","*   The company has secured a stay on an outstanding income tax demand of Rs. 420.36 crore.\n*   This demand relates to a long-pending dispute for the Assessment Year 2008-09.\n*   The stay provides significant short-term relief, averting an immediate cash outflow.\n*   The final liability is still uncertain and depends on the outcome of the company's pending appeal.",{"company_name":15,"filing_date":147,"filing_source":9,"headline":148,"id":149,"stock_code":19,"summary_text":150},"2026-04-29T20:46:41.402000","FY26 Results Show Sharp Profit Drop in Key Segments, Dividend Recommended","69f2212c0c6b4fb98a91ed1e","*   **Performance Snapshot:** Total revenue for FY26 fell 12.6% YoY to ₹14,761.06 Lakhs. Total Profit Before Interest and Tax (PBIT) dropped significantly from ₹6,126.43 Lakhs in FY25 to ₹2,713.92 Lakhs in FY26.\n*   **Segment Red Flags:** Two major segments saw a dramatic negative turnaround. 'Financing and other Activities' swung from a ₹985.07 Lakh profit to a ₹(589.69) Lakh loss. 'Equity, Commodity, Currency and other Transactional Services' fell from a ₹1,789.52 Lakh profit to a ₹(301.15) Lakh loss.\n*   **Shareholder Payout:** The Board has recommended a Final Dividend of ₹0.10 per share (10% on face value), subject to shareholder approval at the upcoming AGM.\n*   **Auditor's Opinion:** The company received an unmodified (clean) audit opinion on its standalone and consolidated financial results for the year ended March 31, 2026.\n*   **Corporate Restructuring:** The Board approved filing an application to strike off the name of an inoperative subsidiary, Divisha Alternative Investments LLP, stating it will have no material impact.",{"company_name":152,"filing_date":153,"filing_source":9,"headline":154,"id":155,"stock_code":108,"summary_text":156},"Adani Total Gas Ltd","2026-04-29T20:46:41.176000","Important Notice: Risk of Share Transfer to IEPF","69f2210e890e096a6fc54edd","*   The company has published a notice regarding the mandatory transfer of equity shares to the Investor Education and Protection Fund (IEPF) Demat Account.\n*   This action is required for shares against which dividends have remained unclaimed for seven consecutive years or more.\n*   Affected shareholders are urged to claim their outstanding dividends and update their KYC details to prevent the transfer of their shares.\n*   A detailed list of shareholders whose shares are liable for transfer is available on the company's website.\n*   This is a routine compliance procedure and not indicative of any adverse operational or financial development.",{"company_name":29,"filing_date":158,"filing_source":9,"headline":159,"id":160,"stock_code":33,"summary_text":161},"2026-04-29T20:46:41.043000","Board Approves Rights Issue to Raise Funds","69f221085236ec998939cb53","*   The Board of Directors has approved a proposal to raise funds through a Rights Issue.\n*   Key documents for the issue, including the Letter of Offer and Application Form, have been approved for filing with the BSE.\n*   **Crucially, the issue size, price, entitlement ratio, and record date have not yet been disclosed.**\n*   A specific ISIN (INE794C20016) has been activated for crediting the dematerialized rights entitlements to eligible shareholders.",{"company_name":7,"filing_date":163,"filing_source":9,"headline":164,"id":165,"stock_code":12,"summary_text":166},"2026-04-29T20:46:41.033000","Q4 Revenue Soars 24%, Proposes ₹24 Dividend","69f2211da157653c6639d26e","*   \u003Cb>Q4 FY26 Revenue Growth:\u003C\u002Fb> Consolidated revenue grew 23.6% year-over-year to ₹176.9 crores.\n*   \u003Cb>Strong Profitability:\u003C\u002Fb> Achieved a consolidated EBITDA margin of 25.6% for the quarter.\n*   \u003Cb>Major Dividend:\u003C\u002Fb> The Board recommended a final dividend of ₹24 per share, representing a 300% payout.\n*   \u003Cb>API Division Recovery:\u003C\u002Fb> Showcased a remarkable 144.3% YoY growth in Q4 after the timely restoration of its manufacturing plant following a fire.\n*   \u003Cb>Market Outperformance:\u003C\u002Fb> The core Domestic Formulations segment grew 18.2%, significantly outpacing the Indian Pharma Market's growth of 10.1%.",{"company_name":168,"filing_date":169,"filing_source":45,"headline":170,"id":171,"stock_code":172,"summary_text":173},"Pramara Promotions Limited","2026-04-29T20:46:39.812000","EGM Scheduled to Approve Capital Raise & Preferential Allotment","69f2210658d874434539ced7","PRAMARA","*   The company has called an Extra-ordinary General Meeting (EGM) for May 21, 2026, to approve several key resolutions.\n*   The main agenda is to seek shareholder approval for a significant capital raise through a preferential issue of both new Equity Shares and Equity Warrants.\n*   This action will lead to equity dilution for existing shareholders upon issuance and future conversion of warrants.\n*   \u003Cb>Key Consideration:\u003C\u002Fb> The identity of the \"certain identified persons\u002Fentities\" who will be allotted the shares and warrants, and the specific purpose for the capital raise, were not disclosed in this filing.",{"company_name":175,"filing_date":176,"filing_source":45,"headline":177,"id":178,"stock_code":144,"summary_text":179},"New Delhi Television Limited","2026-04-29T20:46:39.749000","NDTV Secures Stay on ₹420.36 Crore Tax Demand","69f2210df43b112c8d91e594","*   A stay has been granted on an outstanding income tax demand of ₹420.36 crore for the Assessment Year 2008-09.\n*   This provides immediate relief from a significant potential cash outflow, improving the company's short-term liquidity.\n*   This is a temporary measure, not a final resolution. The stay is active until the company's pending appeal is decided by the Commissioner of Income Tax (Appeals).",{"company_name":74,"filing_date":181,"filing_source":45,"headline":182,"id":183,"stock_code":12,"summary_text":184},"2026-04-29T20:46:39.745000","Strong Q4 Growth & 300% Dividend Recommended","69f22147abd16353d2ff6f95","*   Q4 FY26 revenue grew 23.6% year-over-year to ₹176.9 crores, with the company becoming the 4th fastest-growing pharma company in India.\n*   The API division made a remarkable comeback, growing 144.3% YoY in Q4 following the successful restoration of its manufacturing facility.\n*   The core Domestic Formulation business outpaced the market, growing 18.2% (vs. 10.1% for the Indian Pharma Market).\n*   The Board has recommended a substantial final dividend of ₹24 per share, representing a 300% payout on the share's face value.",{"company_name":168,"filing_date":186,"filing_source":45,"headline":187,"id":188,"stock_code":172,"summary_text":189},"2026-04-29T20:46:39.719000","Announces Major Fundraising Plan of ₹177.39 Crore via Preferential Issue","69f2212bec7f5de862c54828","*   The company proposes to raise up to **₹177.39 Crore** through a preferential issue of equity shares and convertible warrants to non-promoter entities.\n*   The issue price is fixed at **₹365 per share\u002Fwarrant**.\n*   Funds are intended for strategic growth, including manufacturing expansion (₹30 Cr), land acquisition (₹25 Cr), strategic investments (₹30.75 Cr), and working capital (₹30 Cr).\n*   The proposal will cause significant equity dilution, with the **Promoter & Promoter Group's stake decreasing from 32.20% to 23.51%** post-issue.\n*   An Extraordinary General Meeting (EGM) will be held on **May 21, 2026**, to seek shareholder approval.",{"company_name":22,"filing_date":191,"filing_source":9,"headline":192,"id":193,"stock_code":26,"summary_text":194},"2026-04-29T20:41:41.396000","FY26 Results: Crosses Key Revenue Milestones & Hikes Dividend","69f21fdcec7f5de862c54823","*   **Strong Revenue Growth**: Full-year (FY26) revenue grew **23.6% YoY** to ₹35,105 Mn. Q4 revenue was up **32.8% YoY** to ₹10,034 Mn.\n*   **Major Milestones**: Crossed **₹1,000 Crore in quarterly revenue** and **₹3,500 Crore in annual revenue** for the first time.\n*   **Robust Cash Flow**: Cash Flow from Operating Activities surged by **47.3% YoY** for the full year.\n*   **Dividend Increase**: The Board has recommended a final dividend of **₹2.25 per share**, a 12.5% increase over the previous year.\n*   **Strategic Wins**: Reported strong Q4 bookings and highlighted \"breakthrough GenAI-led wins,\" indicating a focus on future growth drivers.",{"company_name":196,"filing_date":197,"filing_source":9,"headline":198,"id":199,"stock_code":200,"summary_text":201},"WSFx Global Pay Ltd","2026-04-29T20:41:41.385000","Confirms It Is Not a 'Large Corporate' for FY26","69f21ff8bf8f716f13ff6cde","511147","• The company has filed a declaration confirming it does not fall under the \"Large Corporate\" category as of March 31, 2026, based on SEBI criteria.\n• As a result, the company is not required to submit the \"Annual Disclosure for Large Corporate Entities\" for the financial year 2025-26.\n• This status indicates the company does not meet the criteria of having outstanding long-term borrowing of ₹100 crore or more and a credit rating of AA and above.\n• Consequently, the company is not mandated to raise a specified portion of its incremental borrowings through debt securities.",{"company_name":203,"filing_date":204,"filing_source":9,"headline":205,"id":206,"stock_code":207,"summary_text":208},"B-Right Realestate Ltd","2026-04-29T20:41:41.366000","Board Meeting on May 2, 2026, to Approve Financial Results","69f21ffbecaa861d9491e998","543543","• A Board of Directors meeting is scheduled for Saturday, May 02, 2026, at 6:00 PM.\n• The primary agenda is to consider and approve the Audited Financial Results (Standalone & Consolidated) for the half-year and year ended March 31, 2026.\n• This intimation is filed under Regulation 29 of the SEBI (LODR) Regulations, 2015.",{"company_name":7,"filing_date":210,"filing_source":9,"headline":211,"id":212,"stock_code":12,"summary_text":213},"2026-04-29T20:41:41.331000","Profit Dips on One-Offs, Dividend Soars & API Biz Restructured","69f2200a58d874434539ced1","*   The Board recommended a strong final dividend of 300% (₹24 per share).\n*   A major strategic move was announced: the API (Active Pharmaceutical Ingredients) division will be transferred to a new wholly-owned subsidiary.\n*   Net Profit for the year fell by 37%, primarily due to a high base in the previous year and significant one-off expenses in FY26.\n*   The profit decline was impacted by a ₹9.16 Cr impairment charge on a failed project and a ₹11.69 Cr provision for new labour codes.\n*   Despite the profit drop, revenue from operations grew by 8.3% for the year.",{"company_name":215,"filing_date":216,"filing_source":45,"headline":217,"id":218,"stock_code":219,"summary_text":220},"Ador Welding Limited","2026-04-29T20:41:40.356000","Dividend Declared, but Segment Losses and a Massive ₹3,643 Lakhs Legal Risk Loom","69f22001abd16353d2ff6f8f","ADOR","*   The core 'Welding' business remains strong, with revenue up 4.1% to ₹1,079 Cr and profit growing 16.9% to ₹164 Cr.\n*   The 'Flares & Process Equipment' segment reported a significant loss of ₹23 Cr, with revenue declining 32% due to major project cost overruns and provisions for damages.\n*   A ₹556 lakh impairment loss was recognized on the investment in the wholly-owned, loss-making subsidiary, 3D Future Technologies Private Limited.\n*   \u003Cb>RED FLAG:\u003C\u002Fb> The company faces a significant contingent liability of ₹3,643 lakhs from a legal dispute with the Bureau of Indian Standards (BIS), for which no financial provision has been made.\n*   Despite challenges, the Board has proposed a final dividend of ₹23 per equity share for FY26.",{"company_name":175,"filing_date":222,"filing_source":45,"headline":223,"id":224,"stock_code":144,"summary_text":225},"2026-04-29T20:41:40.321000","Confirms Full & On-Target Use of ₹396.50 Crore Rights Issue Funds","69f22001a157653c6639d266","*   The company has fully utilized the entire ₹ 396.50 Crore raised from its Rights Issue as of March 31, 2026.\n*   Crucially, there was **zero deviation** from the planned use of funds, indicating strong governance and execution.\n*   A significant portion, **₹ 229.00 Crore**, was used to repay outstanding borrowings, strengthening the company's balance sheet.\n*   An additional **₹ 71.00 Crore** was deployed towards strategic growth initiatives, including marketing, distribution, and IP creation.",{"company_name":74,"filing_date":227,"filing_source":45,"headline":228,"id":229,"stock_code":12,"summary_text":230},"2026-04-29T20:41:40.238000","RPG Life Sciences Announces 300% Dividend & API Business Spin-Off","69f21ffdc9cbead9b3c54bb7","*   **FY26 Results:** Revenue from Operations grew 8.3% to ₹70,752 lakhs. Profit After Tax (PAT) declined 37% to ₹11,517 lakhs, primarily due to a significant reduction in exceptional income compared to the previous year.\n*   **Dividend:** The Board has recommended a final dividend of ₹24 per share (300% of face value), subject to shareholder approval.\n*   **Strategic Restructuring:** The company is transferring its API (Active Pharmaceutical Ingredients) division into a new wholly-owned subsidiary, RPG Active Pharma Limited.\n*   **Exceptional Charges:** Profitability was impacted by one-time charges totaling over ₹2,000 lakhs, related to new labour laws (₹1,169 lakhs) and an asset impairment (₹916 lakhs).\n*   **New Appointment:** Dr. Pratit Samdani was appointed as an Additional Non-Executive Independent Director for a 5-year term.",{"company_name":232,"filing_date":233,"filing_source":45,"headline":234,"id":235,"stock_code":236,"summary_text":237},"Hero MotoCorp Limited","2026-04-29T20:41:40.187000","Board Meeting Scheduled to Consider Final Dividend","69f21fcf890e096a6fc54eca","HEROMOTOCO","*   The Board of Directors is scheduled to meet on **05 May 2026**.\n*   The primary agenda is to consider and recommend a **Final Dividend** for the financial year.\n*   This is a potentially positive development for shareholders, who should monitor the outcome of the meeting for the specific dividend amount.",{"company_name":239,"filing_date":240,"filing_source":45,"headline":241,"id":242,"stock_code":243,"summary_text":244},"EFC (I) Limited","2026-04-29T20:41:39.914000","New Subsidiary Formed for Strategic Asset Restructuring","69f21fd95236ec998939cb47","512008","• The company is incorporating a new subsidiary named **EFC Estate Wakadewadi 2 Private Limited**.\n• This new entity is being created to hold a specific property: the 2nd floor of the Godrej Eternia commercial complex in Pune.\n• The property will be transferred from another subsidiary (EFC Limited) into the new one through a demerger.\n• This is an internal restructuring to ring-fence the asset, with an initial cash investment of just ₹1,000 for incorporation.",{"company_name":51,"filing_date":246,"filing_source":45,"headline":247,"id":248,"stock_code":26,"summary_text":249},"2026-04-29T20:41:39.854000","FY26 Results: Revenue Soars & Dividend Hiked, but Profit Margins Squeezed","69f22054f43b112c8d91e58f","*   FY26 revenue grew 23.6% YoY to ₹35,105 Mn, crossing the ₹3,500 Crore mark.\n*   Q4 FY26 Adjusted Profit Margin contracted sharply to 11.3% from 15.6% YoY, attributed to 'higher non-cash charges'.\n*   Cash Flow from Operations for FY26 grew a robust 47.3% YoY to ₹6,508 Mn.\n*   The Board recommended a final dividend of ₹2.25 per share, a 12.5% increase over last year.",{"company_name":175,"filing_date":251,"filing_source":45,"headline":252,"id":253,"stock_code":144,"summary_text":254},"2026-04-29T20:41:39.830000","Fully Utilizes ₹396.50 Crore Rights Issue Proceeds","69f21fe80c6b4fb98a91ed0f","*   The company has fully utilized the entire ₹396.50 crore raised from its Rights Issue as of March 31, 2026.\n*   Key uses include the full repayment of ₹229 crore in borrowings and a ₹71 crore investment in strategic initiatives.\n*   A material event to note: ₹59.35 crore from the 'General Corporate Purpose' funds was used to settle liabilities of its subsidiary, NDTV Convergence Ltd.\n*   \u003Cb>Red Flag:\u003C\u002Fb> The monitoring agency, CARE Ratings, highlighted the company's \"Weak performance marked by operating losses\" as a key risk.",{"company_name":256,"filing_date":257,"filing_source":45,"headline":258,"id":259,"stock_code":260,"summary_text":261},"Pelatro Limited","2026-04-29T20:41:39.820000","Board Meeting to Consider FY26 Results & Final Dividend","69f21fecf35e30561cff688f","PELATRO","*   A Board Meeting is scheduled for **May 05, 2026**, to consider and approve the Audited Financial Results for the year ended March 31, 2026.\n*   The Board will also consider the recommendation of a **Final Dividend** for the financial year 2025-26.\n*   The trading window for designated persons is closed from April 01, 2026, and will reopen 48 hours after the results are declared.",{"company_name":140,"filing_date":263,"filing_source":9,"headline":264,"id":265,"stock_code":144,"summary_text":266},"2026-04-29T20:36:41.162000","Rights Issue Funds Fully Utilized, But Agency Flags Operating Losses","69f21ebebf8f716f13ff6cd8","• The company has fully utilized the ₹396.50 crore raised from its Rights Issue as of March 31, 2026.\n• The monitoring agency, CARE Ratings, highlighted a key risk: \"Weak performance marked by operating losses.\"\n• A significant portion of the funds (₹59.35 crore) was used to settle historical liabilities of its subsidiary, NDTV Convergence Limited.\n• Despite the performance concerns, the agency confirmed there was \"No deviation\" from the stated objectives for the use of funds.",{"company_name":51,"filing_date":268,"filing_source":45,"headline":269,"id":270,"stock_code":26,"summary_text":271},"2026-04-29T20:36:40.696000","[FY26 Results: Revenue Jumps 24% & Dividend Declared, But Legal Risks Emerge]","69f21ed7a157653c6639d260","*   Consolidated revenue for FY26 grew 23.6% year-over-year to ₹35,105 million, driven by strong performance and recent acquisitions.\n*   The Board has recommended a final dividend of ₹2.25 per equity share for the financial year ended 31 March 2026.\n*   Completed three major acquisitions (Biopharm, Warn & Co, Cake Group) to significantly expand its commercialization services and European footprint.\n*   A provision of ₹203 million has been made as an exceptional item for a proposed settlement in a U.S. class-action lawsuit.\n*   A significant contingent liability of ₹1,114 million has been disclosed due to a transfer pricing tax order, which the company is contesting.",{"company_name":273,"filing_date":274,"filing_source":45,"headline":275,"id":276,"stock_code":277,"summary_text":278},"Syngene International Limited","2026-04-29T20:36:40.543000","Board Recommends Final Dividend of ₹1.25 Per Share","69f21ea2ecaa861d9491e991","SYNGENE","*   The Board of Directors has recommended a **Final Dividend of ₹1.25 per equity share** for the financial year ended 31 March 2026.\n*   This is subject to the approval of shareholders at the upcoming Annual General Meeting (AGM) on 29 July 2026.\n*   The **Record Date** to determine shareholder eligibility for the dividend is Friday, 26 June 2026.\n*   If approved, the dividend will be paid on or before Thursday, 27 August 2026.",{"company_name":273,"filing_date":280,"filing_source":45,"headline":281,"id":282,"stock_code":277,"summary_text":283},"2026-04-29T20:36:40.529000","Strengthens Board with Tech and Biopharma Leaders","69f21ea30c6b4fb98a91ed04","*   The company has appointed three new directors to its Board: Mr. Vijaya Chandru, Mr. Arun Chandavarkar, and Ms. Vinita Bali, effective July 2026.\n*   The appointments significantly enhance the Board's expertise in technology (AI, computational biology), biopharma, and global business leadership.\n*   Mr. Chandru and Mr. Chandavarkar are appointed as Non-Executive Independent Directors, while Ms. Bali is appointed as a Non-Executive Non-Independent Director.\n*   This strategic move strengthens governance and oversight by adding globally recognized leaders with expertise directly relevant to Syngene's business.",{"company_name":285,"filing_date":286,"filing_source":45,"headline":287,"id":288,"stock_code":289,"summary_text":290},"Navin Fluorine International Limited","2026-04-29T20:36:40.387000","Q4 & FY26 Earnings Call Recording Now Available","69f21eaaf43b112c8d91e588","NAVINFLUOR","*   The company has published the audio recording of its earnings call for the quarter and financial year ended March 31, 2026.\n*   Investors can access the recording on the company's website to hear management's discussion on financial and operational performance.\n*   This filing is a regulatory intimation to inform stakeholders where to find the audio and does not contain new financial data itself.",{"company_name":256,"filing_date":292,"filing_source":45,"headline":293,"id":294,"stock_code":260,"summary_text":295},"2026-04-29T20:36:40.317000","Board Meeting to Approve Financials & Consider Dividend","69f21ea2ec7f5de862c5481e","*   A Board Meeting is scheduled for Tuesday, 05-May-2026.\n*   The agenda includes the approval of Audited Financial Results for the year ended 31 March 2026.\n*   The Board will also consider recommending a Final Dividend for the financial year 2025-26.\n*   The trading window for insiders has been closed since 01-April-2026 and will reopen 48 hours after the results are declared.",{"company_name":273,"filing_date":297,"filing_source":45,"headline":298,"id":299,"stock_code":277,"summary_text":300},"2026-04-29T20:36:40.276000","Syngene Appoints S. R. Batliboi & Associates LLP as New Auditor","69f21eaa890e096a6fc54ec0","*   The company has appointed M\u002Fs. S. R. Batliboi & Associates LLP (SRB) as its new Statutory Auditor.\n*   The appointment is for a term of 60 months, with an effective date of July 29, 2026.\n*   This move is viewed as a positive governance step that enhances the credibility and transparency of the company's financial reporting.\n*   The filing was made under the SEBI (LODR) Regulations, 2015, to inform stock exchanges of the change.",{"company_name":302,"filing_date":303,"filing_source":45,"headline":304,"id":305,"stock_code":306,"summary_text":307},"Sanofi India Limited","2026-04-29T20:36:40.247000","Major Board Overhaul & Final Dividend Proposed at AGM","69f21eb05236ec998939cb40","SANOFI","*   A final dividend of ₹48 per share was proposed for the financial year ended Dec 31, 2025. This brings the total dividend for the year to ₹123 per share (including the ₹75 interim dividend).\n*   The company is undergoing a significant leadership transition, with Mr. Rahul Bhatnagar set to become the new Chairman of the Board effective April 30, 2026.\n*   Shareholders voted on numerous board changes, including the appointment of two new Independent Directors and a new Whole-time Director.\n*   Approval was sought for two separate material related party transactions with other Sanofi group entities (Sanofi-Aventis Singapore Pte. Ltd. and Sanofi Healthcare India Pvt. Ltd.).",{"company_name":140,"filing_date":309,"filing_source":9,"headline":310,"id":311,"stock_code":144,"summary_text":312},"2026-04-29T20:32:41.018000","NDTV Fully Utilizes Rights Issue Funds, Repays ₹229 Crore in Debt","69f21e16ecaa861d9491e98d","*   The company has fully utilized the **₹396.50 Crore** raised from its Rights Issue as of March 31, 2026.\n*   There were **no deviations or variations** in the use of funds, which were deployed exactly as stated in the Letter of Offer.\n*   A significant portion, **₹229 Crore (58% of proceeds), was used to repay debt**, strengthening the company's balance sheet and reducing financial risk.\n*   The remaining funds were allocated to strategic growth initiatives (₹71 Crore) and general corporate purposes (₹96.50 Crore).\n*   The company's Audit Committee reviewed and confirmed the proper utilization of funds with no adverse comments.",{"company_name":314,"filing_date":315,"filing_source":9,"headline":316,"id":317,"stock_code":318,"summary_text":319},"Monarch Surveyors and Engineering Consultants Ltd","2026-04-29T20:32:21.098000","FY26 Results: Revenue Up 11%, IPO Funds Largely Unutilized","69f21db70c6b4fb98a91ecfd","544453","*   **FY26 Financials:** Revenue from Operations grew 11.4% YoY to ₹17,169.06 Lakhs, while Profit After Tax (PAT) rose 6.9% to ₹3,723.36 Lakhs.\n*   **IPO Update:** The company successfully completed an IPO in July 2025, raising total proceeds of ₹93.75 Crores.\n*   **Slow Fund Utilization:** A significant portion of the IPO proceeds (₹66.43 Crores, or ~71%) remains unutilized as of March 31, 2026, and is currently invested in fixed deposits.\n*   **Clean Audit Report:** The statutory auditors have issued an unmodified (clean) opinion on the financial results.",{"company_name":22,"filing_date":321,"filing_source":9,"headline":322,"id":323,"stock_code":26,"summary_text":324},"2026-04-29T20:32:21.044000","FY26 Results: Revenue Up 24%, Dividend Declared, But Legal Issues Weigh on Profit","69f21ddeabd16353d2ff6f7f","*   Revenue grew 23.6% YoY to ₹35,105 million, but Profit After Tax remained flat at ₹4,011 million due to an exceptional item.\n*   The Board has recommended a final dividend of ₹2.25 per equity share for FY26.\n*   Completed three major acquisitions (BioPharm, Warn & Co, Cake Group) as part of an aggressive inorganic growth strategy.\n*   Made a provision of ₹203 million for a US class-action lawsuit, which suppressed net profit.\n*   Disclosed a significant contingent liability of ₹1,114 million related to a draft transfer pricing order.",{"company_name":326,"filing_date":327,"filing_source":9,"headline":328,"id":329,"stock_code":289,"summary_text":330},"Navin Fluorine International Ltd","2026-04-29T20:32:20.997000","Q4 & FY26 Earnings Call Recording Now Live","69f21da4890e096a6fc54eb6","*   The company has published the audio recording of its earnings call for the quarter and financial year ended March 31, 2026.\n*   The call discusses the company's financial and operational performance for the period.\n*   Investors can access the recording on the company's website at: `https:\u002F\u002Fwww.nfil.in\u002Finvestor\u002Fpdf\u002F2026\u002FNFILQ4FY26.mp3`\n*   This filing is a procedural notification; no new financial data or material information is disclosed in the document itself.",{"company_name":239,"filing_date":332,"filing_source":45,"headline":333,"id":334,"stock_code":243,"summary_text":335},"2026-04-29T20:31:39.414000","EFC (I) Ltd Forms New Subsidiary for Planned Asset Demerger","69f21db7bf8f716f13ff6cd1","• EFC (I) Ltd has incorporated a new wholly-owned subsidiary named EFC Estate Wakadewadi 2 Private Limited.\n• The new subsidiary is being set up to hold a specific real estate asset: the 2nd floor of the Godrej Eternia commercial complex in Pune.\n• The filing indicates a plan to transfer this asset into the new subsidiary via a demerger, a significant corporate restructuring event that will require future approvals.\n• This strategic move is to create a separate legal entity for asset management, consistent with the company's \"Real estate as a service\" business line.",{"company_name":337,"filing_date":338,"filing_source":45,"headline":339,"id":340,"stock_code":341,"summary_text":342},"City Union Bank Limited","2026-04-29T20:31:39.315000","Seeks Shareholder Approval for Bonus Issue & Director Appointment","69f21d97a157653c6639d257","CUB","*   The bank has initiated a Postal Ballot to seek shareholder approval for two key resolutions.\n*   **Bonus Issue:** To approve the issuance of Bonus securities. **(Note: The filing critically lacks details on the bonus ratio or record date.)**\n*   **Director Appointment:** To approve the appointment of Shri R Mohan as a Non-Executive Independent Director from April 27, 2026, to May 15, 2030.\n*   The e-voting period is scheduled from April 30, 2026, to May 29, 2026.",{"company_name":74,"filing_date":344,"filing_source":45,"headline":345,"id":346,"stock_code":12,"summary_text":347},"2026-04-29T20:31:39.280000","Recommends ₹24 Dividend; PAT Dips on High Base Effect","69f21da5f35e30561cff6886","\u003Cul>\n    \u003Cli>The Board has recommended a final dividend of \u003Cb>₹24 per share\u003C\u002Fb> (300% payout) for the financial year 2025-26, subject to shareholder approval.\u003C\u002Fli>\n    \u003Cli>FY26 Profit After Tax (PAT) fell 37.15% to ₹11,517 lakhs. This is primarily due to a large one-off income in the previous year; \u003Cb>core operational profit was flat\u003C\u002Fb> year-over-year.\u003C\u002Fli>\n    \u003Cli>The company is proceeding with the transfer of its API (Active Pharmaceutical Ingredients) business to its new wholly-owned subsidiary, RPG Active Pharma Limited.\u003C\u002Fli>\n    \u003Cli>An exceptional expense of \u003Cb>₹916 lakhs\u003C\u002Fb> was booked for the impairment of an 'Intangible Asset Under Development', indicating a project write-off.\u003C\u002Fli>\n    \u003Cli>Appointed \u003Cb>Dr. Pratit Samdani\u003C\u002Fb> as a new Additional Non-Executive Independent Director for a 5-year term.\u003C\u002Fli>\n\u003C\u002Ful>",{"company_name":7,"filing_date":349,"filing_source":9,"headline":350,"id":351,"stock_code":12,"summary_text":352},"2026-04-29T20:26:43.092000","Posts FY26 Results, Declares 300% Dividend & Plans API Business Transfer","69f21c78c9cbead9b3c54ba0","*   **Financial Performance:** Net Profit (PAT) for FY26 stood at ₹115 Cr, down 37% YoY. The decline is primarily due to a large one-off gain from a land sale in the previous year; core profit before exceptional items remained flat, indicating stable operations. Revenue grew 8.3% to ₹708 Cr.\n*   **Dividend Payout:** The Board has recommended a final dividend of ₹24 per share (300% of face value) for the financial year 2025-26, subject to shareholder approval.\n*   **Major Restructuring:** The company is proceeding with its plan to transfer the API (Active Pharmaceutical Ingredient) division to its newly incorporated wholly-owned subsidiary, RPG Active Pharma Limited.\n*   **Exceptional Items:** The year's results were impacted by one-off charges, including ₹11.7 Cr for new Labour Codes and a ₹9.2 Cr write-off for an intangible asset.\n*   **Board Appointment:** Dr. Pratit Samdani, a respected physician, has been appointed as an Additional Non-Executive Independent Director for a 5-year term.",{"company_name":354,"filing_date":355,"filing_source":9,"headline":356,"id":357,"stock_code":358,"summary_text":359},"AXIS Bank Ltd","2026-04-29T20:26:42.976000","RBI Approves Re-appointment of Whole-Time Director","69f21c59ecaa861d9491e983","532215","*   The Reserve Bank of India (RBI) has approved the re-appointment of **Mr. Subrat Mohanty** as the Whole-Time Director (designated as Executive Director).\n*   The re-appointment is for a period of three years, effective from August 17, 2026, to August 16, 2029.\n*   This re-appointment remains subject to the approval of the Bank's shareholders.",{"company_name":361,"filing_date":362,"filing_source":9,"headline":363,"id":364,"stock_code":236,"summary_text":365},"Hero MotoCorp Ltd","2026-04-29T20:26:42.865000","Board Meeting on May 5 to Discuss FY26 Results & Dividend","69f21c6a0c6b4fb98a91ecf5","*   The Board of Directors will meet on \u003Cb>Tuesday, May 5, 2026\u003C\u002Fb>.\n*   The agenda includes approving the audited financial results for the quarter and year ended March 31, 2026.\n*   The Board will also consider the declaration of a \u003Cb>final dividend\u003C\u002Fb> for the financial year 2025-26.",{"company_name":367,"filing_date":368,"filing_source":9,"headline":369,"id":370,"stock_code":243,"summary_text":371},"EFC (I) Ltd","2026-04-29T20:26:42.846000","Forms New Subsidiary for Strategic Asset Restructuring","69f21c8cf35e30561cff6881","*   Incorporated a new 100% wholly-owned subsidiary named **EFC Estate Wakadewadi 2 Private Limited**.\n*   The new entity is created to hold a specific property located at Godrej Eternia, Shivaji Nagar, Pune.\n*   This is part of an internal restructuring; the property will be demerged from another material subsidiary, **EFC Limited**, and moved into the new entity.\n*   The move creates a Special Purpose Vehicle (SPV) for the asset, providing strategic flexibility for future sales, joint ventures, or financing.\n*   Initial investment is a nominal ₹1,000, confirming this as an asset reorganization rather than a new cash purchase.",{"company_name":373,"filing_date":374,"filing_source":9,"headline":375,"id":376,"stock_code":306,"summary_text":377},"Sanofi India Ltd","2026-04-29T20:26:42.827000","AGM Results: ₹123 Dividend Declared & All Resolutions Passed Despite Minority Dissent","69f21c91a157653c6639d251","*   **AGM Outcome:** All 11 resolutions proposed at the 70th Annual General Meeting (AGM) were passed with the requisite majority.\n*   **Dividend Declared:** A total dividend of ₹123 per share was approved for the financial year 2025 (₹75 interim + ₹48 final).\n*   **Board Changes:** Shareholders approved the appointment of Ms. Sudipta Chakraborty as Whole-time Director and the appointments of Ms. Rajani Kesari and Mr. Siraj Azmat Chaudhry as Independent Directors.\n*   **Shareholder Dissent:** Notably, several resolutions faced significant opposition (over 28% 'against' votes) from public non-institutional shareholders. All resolutions still passed due to the Promoter group's ~60.4% holding and favourable vote.\n*   **Related Party Transactions:** Approval was granted for material RPTs with Sanofi-Aventis Singapore Pte. Limited and Sanofi Healthcare India Private Limited.",{"company_name":379,"filing_date":380,"filing_source":9,"headline":381,"id":382,"stock_code":383,"summary_text":384},"Lloyds Metals and Energy Ltd","2026-04-29T20:26:42.809000","Announces Earnings Call for Q4 & FY26 Results","69f21c77bf8f716f13ff6cc9","LLOYDSME","• The company will host an Earnings Conference Call to discuss its audited financial results for the quarter (Q4) and financial year (FY26).\n• The call is scheduled for Wednesday, 06th May, 2026, at 03:30 P.M. IST.\n• Key management, including the Managing Director and CFO, will be present to discuss performance and answer questions.\n• This intimation was filed with the BSE and NSE in compliance with SEBI regulations.",{"company_name":386,"filing_date":387,"filing_source":45,"headline":388,"id":389,"stock_code":19,"summary_text":390},"Systematix Corporate Services Limited","2026-04-29T20:26:40.143000","Profit Plummets 70% Amid Segment Losses and Regulatory Scrutiny","69f21cadabd16353d2ff6f7a","• \u003Cb>Sharp Profit Decline:\u003C\u002Fb> Consolidated Profit After Tax (PAT) for FY26 fell by ~70% to ₹1,383.71 Lakhs from ₹4,576.13 Lakhs in FY25.\n• \u003Cb>EPS Plummets:\u003C\u002Fb> Basic Earnings Per Share (EPS) dropped significantly to ₹1.01 from ₹3.46 in the previous year.\n• \u003Cb>Segmental Losses:\u003C\u002Fb> Two of the three main business segments ('Financing' and 'Equity\u002FCommodity Services') swung from profit to significant losses.\n• \u003Cb>Dividend Recommended:\u003C\u002Fb> The Board has proposed a final dividend of ₹0.10 per share, subject to shareholder approval.\n• \u003Cb>Major Regulatory Risk:\u003C\u002Fb> A subsidiary faces a pending legal battle against a SEBI order to cancel its registration, creating significant uncertainty for future operations.",{"company_name":392,"filing_date":393,"filing_source":45,"headline":394,"id":395,"stock_code":396,"summary_text":397},"Axis Bank Limited","2026-04-29T20:26:39.823000","RBI Greenlights Re-appointment of Executive Director Subrat Mohanty","69f21c56ec7f5de862c54813","AXISBANK","*   The Reserve Bank of India (RBI) has approved the re-appointment of \u003Cb>Mr. Subrat Mohanty\u003C\u002Fb> as the Whole-Time Director (designated as Executive Director).\n*   The new term is for a period of three years, effective from August 17, 2026, to August 16, 2029.\n*   The re-appointment is still subject to approval by the Bank's shareholders.",{"company_name":399,"filing_date":400,"filing_source":45,"headline":401,"id":402,"stock_code":383,"summary_text":403},"Lloyds Metals And Energy Limited","2026-04-29T20:26:39.822000","Announces Q4 & FY26 Earnings Conference Call","69f21c56890e096a6fc54ea8","*   The company will host a conference call on Tuesday, 06th May, 2026, to discuss its financial results.\n*   The call will cover the Audited Financial Results for the Quarter and Financial Year ended 31st March, 2026.\n*   Senior management, including the Managing Director (Mr. Rajesh Gupta) and CFO (Mr. Riyaz Shaikh), will be present.\n*   The event, hosted by Equirus Securities, will include an interactive Q&A session for investors and analysts.",{"company_name":405,"filing_date":406,"filing_source":45,"headline":407,"id":408,"stock_code":409,"summary_text":410},"UNO Minda Limited","2026-04-29T20:26:39.818000","Lost Share Certificate Reported","69f21c5b5236ec998939cb35","UNOMINDA","*   A shareholder, Challagalla Venkateshwara Prasad, has reported the loss of a share certificate representing 304 shares.\n*   The company has received the intimation and will issue a duplicate certificate after completing the necessary formalities.\n*   This is a routine procedural filing under SEBI regulations and is not considered a material event impacting the company's performance.\n*   Details: Folio No: 0003969, Certificate No: 35252.",{"company_name":412,"filing_date":413,"filing_source":9,"headline":414,"id":415,"stock_code":219,"summary_text":416},"Ador Welding Ltd","2026-04-29T20:21:40.928000","FY26 Results: Dividend Up, But Project & Subsidiary Woes Continue","69f21b5d0c6b4fb98a91ecef","*   **Dividend Declared:** The Board has proposed a final dividend of **₹23 per equity share** for the financial year 2025-26.\n*   **Segment Underperformance:** The 'Flares & Process Equipment' segment reported a significant loss of **₹2,306 lakhs**, driven by a **₹2,482 lakh** provision for cost overruns and damages on a single turnkey project.\n*   **Subsidiary Drain:** The company booked an exceptional loss of **₹556 lakhs** as a provision against its investment in its loss-making subsidiary, 3D Future Technologies, which follows a ₹3,171 lakh provision in the prior year.\n*   **Major Un-provisioned Risk:** A **contingent liability of ₹3,643 lakhs** related to a dispute with the Bureau of Indian Standards (BIS) is not provided for in the financial statements.\n*   **One-Off Gain:** Profits were significantly boosted by a one-off income of **₹1,412 lakhs** from the recovery of previously written-off receivables.",{"company_name":418,"filing_date":419,"filing_source":9,"headline":420,"id":421,"stock_code":409,"summary_text":422},"UNO Minda Ltd","2026-04-29T20:21:40.905000","Notice of Lost Share Certificate","69f21ba7890e096a6fc54ea3","- The company has notified exchanges about a shareholder's report of a lost share certificate.\n- The request is from shareholder Challagalla Venkateshwara Prasad for 304 shares.\n- A duplicate certificate will be issued after the completion of necessary procedures.\n- This is a routine administrative filing and is not considered material to the company's financial health or operations.",{"company_name":424,"filing_date":425,"filing_source":9,"headline":426,"id":427,"stock_code":428,"summary_text":429},"Geojit Financial Services Ltd","2026-04-29T20:21:40.797000","FY26 Net Profit Plummets 52% Despite Dividend Announcement","69f21b4a5236ec998939cb30","GEOJITFSL","*   **Annual Profit Collapse:** Full-year Net Profit (PAT) for FY26 fell sharply by 52% to ₹83.58 crore, down from ₹172.49 crore in the previous year.\n*   **Severe Margin Squeeze:** In Q4, Net Profit dropped 46% year-over-year, even though revenue grew by 7%, highlighting significant pressure on profitability.\n*   **Dividend Declared:** The Board has recommended a final dividend of ₹1.50 per share (150%) for the financial year 2025-26, subject to shareholder approval.\n*   **Primary Red Flag:** The severe deterioration in profitability is the main concern, as the 52% drop in annual profit far outweighs the 10% decline in revenue.",{"company_name":431,"filing_date":432,"filing_source":45,"headline":433,"id":434,"stock_code":428,"summary_text":435},"Geojit Financial Services Limited","2026-04-29T20:21:40.177000","Annual Profit Halves, Board Proposes ₹1.50 Dividend","69f21b3158d874434539ceab","*   Full-year Profit After Tax (PAT) for FY26 fell sharply by 52% to ₹83.58 crore, while annual revenue declined by 10%.\n*   For the latest quarter (Q4 FY26), Profit After Tax was down 46% year-over-year to ₹17.47 crore, despite a 7% increase in revenue.\n*   The Board has recommended a dividend of ₹1.50 per share (150%) for the financial year 2025-26, subject to shareholder approval.\n*   As of March 31, 2026, the company manages customer assets worth ₹97,056 crore and serves 16.68 lakh clients.",{"company_name":386,"filing_date":437,"filing_source":45,"headline":438,"id":439,"stock_code":19,"summary_text":440},"2026-04-29T20:21:40.068000","FY26 Results: Dividend Declared Amidst Segment Declines and Regulatory Challenges","69f21b46a157653c6639d248","*   The Board recommended a Final Dividend of \u003Cb>₹0.10 per share\u003C\u002Fb> for FY26, subject to shareholder approval.\n*   Two of three business segments (Financing; Equity & Commodity Services) became loss-making, causing total net income to drop \u003Cb>12.6% YoY\u003C\u002Fb>.\n*   The Merchant Banking segment was the only one to grow, with revenue up \u003Cb>13.85%\u003C\u002Fb> and profit (PBIT) up 7.55%.\n*   \u003Cb>Major Risk:\u003C\u002Fb> A key subsidiary faces a significant regulatory challenge from SEBI regarding its registration, creating major business uncertainty for a core segment.\n*   \u003Cb>Red Flags:\u003C\u002Fb> Auditors highlighted inconsistent segment disclosures and reliance on unaudited financials for a subsidiary, raising governance concerns.",{"company_name":442,"filing_date":443,"filing_source":45,"headline":444,"id":445,"stock_code":446,"summary_text":447},"Capital Small Finance Bank Limited","2026-04-29T20:21:39.838000","FY26 Results: Advances Up 21%, Profitability Dips","69f21b62f35e30561cff687b","CAPITALSFB","*   Gross Advances grew 21% YoY to ₹8,687 Cr, and Total Deposits rose 20% YoY to ₹10,018 Cr.\n*   Profit After Tax (PAT) grew a modest 7% to ₹141 Cr, impacted by a one-time charge. Key profitability metrics like Net Interest Margin (NIM) and Return on Assets (RoA) declined.\n*   Overall asset quality remained stable (Net NPA at 1.24%), but the MFI loan sub-segment showed an extremely high Net NPA of 17.30%, a significant red flag.\n*   Management unveiled 'Vision 2029', aiming to double advances to ₹16k+ Cr and improve RoA to over 1.6%.",{"company_name":302,"filing_date":449,"filing_source":45,"headline":450,"id":451,"stock_code":306,"summary_text":452},"2026-04-29T20:21:39.759000","AGM Results: Dividend Approved, Board Changes Pass Despite Dissent","69f21b4cabd16353d2ff6f73","• Shareholders approved a total dividend of ₹123 per share for the financial year 2025.\n• All 11 resolutions were passed, including the appointment of two new Independent Directors and the re-appointment of two directors.\n• **Key Red Flag:** Significant dissent was noted from public non-institutional shareholders, with over 28% voting against several director appointments, despite the resolutions passing due to promoter support.\n• Two material Related Party Transactions (RPTs) were approved.",{"company_name":454,"filing_date":455,"filing_source":45,"headline":456,"id":457,"stock_code":458,"summary_text":459},"MITCON Consultancy & Engineering Services Limited","2026-04-29T20:21:39.726000","Major Board Reshuffle Announced","69f21b5cf43b112c8d91e569","MITCON","*   Mr. Anand Chalwade has been re-appointed as Managing Director for a further 5-year term.\n*   Mr. Prakash Vaidya, an expert in energy transition, has been appointed as a new Additional (Independent) Director.\n*   Mr. Manjunath Jyothinagara has resigned as a Non-Executive Independent Director.\n*   \u003Cb>Key Governance Change:\u003C\u002Fb> Mr. Sanjay Phadke resigned as an Independent Director and was simultaneously re-categorized as a Non-Executive Non-Independent Director, as he no longer meets the criteria for independence.",{"company_name":461,"filing_date":462,"filing_source":9,"headline":463,"id":464,"stock_code":465,"summary_text":466},"Aditya Birla Capital Ltd","2026-04-29T20:16:44.310000","Allots Equity Shares Under Employee Schemes","69f21a07a157653c6639d23e","ABCAPITAL","*   The company has allotted **20,608 new equity shares** to employees under its stock option schemes (ESOPs) on 29 April 2026.\n*   This action increases the total paid-up share capital to **2,62,05,42,896 shares**.\n*   The issuance represents a minor equity dilution of approximately **0.000786%** for existing shareholders.\n*   All newly allotted shares will rank on equal footing (`pari passu`) with existing equity shares.",{"company_name":468,"filing_date":469,"filing_source":9,"headline":470,"id":471,"stock_code":472,"summary_text":473},"Amarjothi Spinning Mills Ltd","2026-04-29T20:16:44.145000","Action Required: Important Update on Dividend Payments & KYC","69f21a0bf35e30561cff6874","521097","*   \u003Cb>Major Policy Change:\u003C\u002Fb> The company will stop issuing physical dividend warrants from 18th November 2025. All future dividends will be paid exclusively through electronic modes.\n*   \u003Cb>Action Required for Shareholders:\u003C\u002Fb> You must update your KYC, bank account details, and nominee information to receive future dividends. Shareholders without updated bank details will not be paid.\n*   \u003Cb>Risk of Loss:\u003C\u002Fb> If dividends remain unclaimed for seven consecutive years, both the dividend amount and the corresponding shares will be transferred to the Investor Education and Protection Fund (IEPF).\n*   \u003Cb>Shareholder Campaign:\u003C\u002Fb> This notice is part of the \"Saksham Niveshak\" campaign (1st April 2026 - 9th July 2026) urging shareholders to claim unpaid amounts and update records.\n*   \u003Cb>Contact for Updates:\u003C\u002Fb> Shareholders should contact the company's Registrar and Transfer Agent, M\u002Fs. Cameo Corporate Services Limited, for any updates or claims.",{"company_name":475,"filing_date":476,"filing_source":9,"headline":477,"id":478,"stock_code":479,"summary_text":480},"Orient Cement Ltd","2026-04-29T20:16:44.032000","Urgent Notice: Update Your KYC to Prevent Loss of Dividends","69f219f758d874434539cea0","ORIENTCEM","*   The company has published a newspaper notice urging shareholders to update their KYC and other details to prevent unpaid dividends from being transferred to the government's Investor Education and Protection Fund (IEPF).\n*   This is a critical call to action for shareholders, as failing to update their information could result in their funds being transferred, making them more complex to claim later.\n*   The notice is part of the \"Saksham Niveshak\" campaign aimed at ensuring shareholders receive their rightful dividends.\n*   This filing serves as proof of the newspaper publication made on April 28, 2026, in compliance with SEBI regulations.",{"company_name":482,"filing_date":483,"filing_source":9,"headline":484,"id":485,"stock_code":486,"summary_text":487},"Hexaware Technologies Ltd","2026-04-29T20:16:44.022000","Approves Grant of 1.93 Lakh Stock Options","69f21a01f43b112c8d91e563","HEXT","*   The company's Nomination and Remuneration Committee has approved the grant of **1,93,700 stock options** to eligible employees.\n*   This grant is made under the \"Hexaware Employees Stock Option Plan 2024\".\n*   The exercise price for these options is set at **₹382.5 per share**.\n*   Upon exercise, this will result in the issuance of new equity shares, leading to potential **dilution of earnings per share** for existing shareholders.",{"company_name":489,"filing_date":490,"filing_source":9,"headline":491,"id":492,"stock_code":446,"summary_text":493},"Capital Small Finance Bank Ltd","2026-04-29T20:16:44.003000","Posts Strong Q4 & FY26 Growth, Unveils 'Vision 2029' Strategy","69f21af3890e096a6fc54ea0","*   📈 \u003Cb>Strong Growth:\u003C\u002Fb> Gross Advances surged 21% YoY to ₹8,687 Cr, while Deposits grew 20% YoY to ₹10,018 Cr for the year ended March 31, 2026.\n*   💰 \u003Cb>Profitability Boost:\u003C\u002Fb> Q4FY26 Profit After Tax (PAT) increased by 17% YoY. Net Interest Margin (NIM) showed signs of improvement at 4.06%.\n*   🎯 \u003Cb>'Vision 2029' Unveiled:\u003C\u002Fb> The bank announced a long-term strategy to double its loan book to ₹16k+ Cr, expand its branch network to 300+, and target a Return on Assets (RoA) of 1.6%++.\n*   ✅ \u003Cb>Stable Asset Quality:\u003C\u002Fb> Maintained a healthy Net NPA of 1.24% and a robust Capital Adequacy Ratio (CRAR) of 22.3%.\n*   ⚠️ \u003Cb>Key Developments:\u003C\u002Fb> The bank reported a one-time exceptional charge of ₹4 Cr (net) in FY26 and announced a key management reshuffle in its risk and credit functions.",{"company_name":386,"filing_date":495,"filing_source":45,"headline":496,"id":497,"stock_code":19,"summary_text":498},"2026-04-29T20:16:42.298000","Mixed Results: Dividend Declared Despite 56% Profit Drop & Regulatory Woes","69f21a5b0c6b4fb98a91ece9","• FY26 consolidated profit before interest and tax (PBIT) plummeted by 55.7% to ₹27.1 Cr from ₹61.2 Cr in FY25, driven by heavy losses in two key segments.\n• Despite the profit decline, the Board has recommended a final dividend of ₹0.10 per share, subject to shareholder approval.\n• The sharp decline was caused by the 'Financing' and 'Equity\u002FCommodity' segments, which both swung from profit to significant losses. 'Merchant Banking' was the only segment to post growth.\n• A major subsidiary is facing a significant regulatory challenge from SEBI regarding its registration cancellation, creating business continuity risk. The matter is currently pending adjudication.\n• The core standalone company remains profitable, indicating that the severe performance decline and losses are concentrated within its subsidiaries.",{"company_name":405,"filing_date":500,"filing_source":45,"headline":501,"id":502,"stock_code":409,"summary_text":503},"2026-04-29T20:16:42.155000","Shareholder Reports Lost Certificate","69f21a0fabd16353d2ff6f6c","*   The company has received an intimation regarding the loss of a physical share certificate from a shareholder.\n*   The lost certificate pertains to 304 shares held by shareholder Challagalla Venkateshwara Prasad.\n*   A duplicate share certificate will be issued after the completion of required formalities.\n*   This is a routine administrative disclosure with no material financial or operational impact on the company.",{"company_name":505,"filing_date":506,"filing_source":45,"headline":507,"id":508,"stock_code":509,"summary_text":510},"Picturepost Studios Limited","2026-04-29T20:16:42.152000","Confirms Share Dematerialization Status for Q4 FY26","69f21a05890e096a6fc54e99","PPSL","*   Submitted a compliance certificate for the quarter ended March 31, 2026, as per SEBI regulations.\n*   Confirmed that all company shares remain in dematerialized (demat) form.\n*   No requests for rematerialization of shares were received from shareholders during the quarter.\n*   The filing is a routine compliance update and contains no other material information on financials or corporate actions.",{"company_name":512,"filing_date":513,"filing_source":45,"headline":514,"id":515,"stock_code":486,"summary_text":516},"Hexaware Technologies Limited","2026-04-29T20:16:42.087000","Approves Grant of 193,700 Employee Stock Options","69f219f9ecaa861d9491e96c","*   The Nomination and Remuneration Committee has granted **1,93,700 Employee Stock Options (ESOPs)** to eligible employees under the \"Hexaware Employees Stock Option Plan 2024\".\n*   The exercise price for these options is fixed at **₹382.5 per share**.\n*   This grant creates a **potential for future equity dilution** for shareholders, as it could result in the issuance of 1,93,700 new shares if all options are exercised.\n*   The action was approved in a committee meeting on **April 29, 2026**.",{"company_name":518,"filing_date":519,"filing_source":9,"headline":520,"id":521,"stock_code":522,"summary_text":523},"Motilal Oswal Financial Services Ltd","2026-04-29T20:11:41.311000","Grants 2.34 Million Stock Options to Employees","69f21904f43b112c8d91e55e","MOTILALOFS","\u003Cul>\n    \u003Cli>The Nomination and Remuneration Committee has approved the grant of \u003Cb>23,46,452 Stock Options\u003C\u002Fb> to eligible employees.\u003C\u002Fli>\n    \u003Cli>This grant is intended as a long-term incentive and retention tool for employees.\u003C\u002Fli>\n    \u003Cli>For existing shareholders, this action represents \u003Cb>potential future equity dilution\u003C\u002Fb> when the options are exercised.\u003C\u002Fli>\n    \u003Cli>The grant was approved and filed with the stock exchanges on April 29, 2026.\u003C\u002Fli>\n\u003C\u002Ful>",{"company_name":525,"filing_date":526,"filing_source":45,"headline":287,"id":527,"stock_code":528,"summary_text":529},"Granules India Limited","2026-04-29T20:11:40.432000","69f219120c6b4fb98a91ece3","GRANULES","*   The audio recording of the earnings conference call for the fourth quarter (Q4) and the financial year ended March 31, 2026, is now available on the company's website.\n*   This filing is a compliance update under SEBI regulations and serves to notify stakeholders about the availability of the recording.\n*   The document itself does not contain financial results or operational highlights; it only provides a link to the audio.\n*   This action enhances transparency by providing investors and analysts direct access to management's discussion on performance and outlook.",{"company_name":405,"filing_date":531,"filing_source":45,"headline":532,"id":533,"stock_code":409,"summary_text":534},"2026-04-29T20:11:40.312000","Intimation of Lost Share Certificate","69f218e95236ec998939cb25","*   The company has received a request for a duplicate share certificate from a shareholder, Challagalla Venkateshwara Prasad, who reported the loss of the original.\n*   The lost certificate pertains to 304 shares (Folio No. 0003969).\n*   A duplicate certificate will be issued after the shareholder completes the required formalities as per SEBI guidelines.\n*   This is a routine administrative filing with no material financial or operational impact on the company.",{"company_name":536,"filing_date":537,"filing_source":45,"headline":538,"id":539,"stock_code":479,"summary_text":540},"Orient Cement Limited","2026-04-29T20:11:40.296000","Shareholders Urged to Update KYC to Avoid Folio Freeze","69f218d5f35e30561cff686d","*   The company has published a notice urging shareholders to update their KYC, PAN, bank, and nomination details.\n*   \u003Cb>Warning:\u003C\u002Fb> Failure to furnish valid PAN or complete KYC may lead to the freezing of shareholder accounts (folios).\n*   Shares with dividends that have been unpaid or unclaimed for seven consecutive years will be mandatorily transferred to the Investor Education and Protection Fund (IEPF).",{"company_name":542,"filing_date":543,"filing_source":9,"headline":544,"id":545,"stock_code":546,"summary_text":547},"Shri Dinesh Mills Ltd","2026-04-29T20:06:41.976000","Board Approves Demerger Plan to Split Company","69f217b9c9cbead9b3c54b84","503804","*   The Board has given in-principle approval to demerge its \"FELT Business\" into a new, separate company that will also be listed.\n*   This restructuring is driven by a Family Settlement Agreement between the promoter families (BUP & NUP families) to separate management and control.\n*   Post-demerger, the BUP family will control the existing company (Shri Dinesh Mills Ltd.), and the NUP family will control the new company housing the FELT Business.\n*   Public shareholders are expected to receive shares in the new demerged company as per the scheme of arrangement.\n*   The entire plan is subject to approvals from the National Company Law Tribunal (NCLT) and other regulatory authorities.",{"company_name":549,"filing_date":550,"filing_source":9,"headline":551,"id":552,"stock_code":553,"summary_text":554},"Welspun Enterprises Ltd","2026-04-29T20:06:41.934000","Secures Strong Credit Ratings from ICRA","69f217a55236ec998939cb1f","WELENT","*   ICRA has assigned new, high-quality credit ratings to the company's bank facilities totaling ₹400 crore.\n*   Long-term facilities (₹350 crore) received a rating of **[ICRA]AA** with a **Stable** outlook, indicating a high degree of safety.\n*   Short-term facilities (₹50 crore) were rated **[ICRA]A1+**, indicating a very strong degree of safety.\n*   This strong rating is a positive development that enhances the company's financial flexibility and investor confidence.",{"company_name":556,"filing_date":557,"filing_source":45,"headline":558,"id":559,"stock_code":465,"summary_text":560},"Aditya Birla Capital Limited","2026-04-29T20:06:39.235000","Allots 20,608 Equity Shares Under Employee Stock Option Schemes","69f217aa58d874434539ce94","*   The company has allotted **20,608 new equity shares** of face value ₹10 each to employees upon the exercise of stock options.\n*   This allotment was made under the ABCL Employee Stock Option Schemes of 2017 and 2022.\n*   The company's paid-up share capital has increased by **₹2,06,080** to ₹26,20,54,28,960.\n*   The action results in a minor equity dilution of approximately **0.00079%** for existing shareholders.",{"company_name":556,"filing_date":562,"filing_source":45,"headline":563,"id":564,"stock_code":465,"summary_text":565},"2026-04-29T20:06:39.205000","New Equity Shares Allotted Under ESOP","69f217b6f35e30561cff6868","*   Allotted **20,608** new equity shares upon the exercise of employee stock options (ESOP).\n*   The company's listed paid-up share capital has increased to **2,620,542,896** shares.\n*   This action results in a minor equity dilution of approximately **0.00079%**.\n*   The date of allotment was April 29, 2026.",{"company_name":567,"filing_date":568,"filing_source":45,"headline":569,"id":570,"stock_code":553,"summary_text":571},"Welspun Enterprises Limited","2026-04-29T20:06:39.173000","Secures High-Grade Credit Ratings from ICRA","69f217a7abd16353d2ff6f5a","*   ICRA has assigned new credit ratings to the company's bank facilities aggregating to **₹400 Crore**.\n*   Long-term facilities of ₹350 Crore have been rated **`[ICRA]AA (Stable)`**, indicating high credit quality.\n*   Short-term facilities of ₹50 Crore have been rated **`[ICRA]A1+`**, indicating a very strong degree of safety.\n*   This is a positive development, signifying strong financial stability and enhancing creditor confidence.",{"company_name":573,"filing_date":574,"filing_source":45,"headline":575,"id":576,"stock_code":522,"summary_text":577},"Motilal Oswal Financial Services Limited","2026-04-29T20:06:39.147000","Grants Over 2.3 Million Stock Options to Employees","69f217b2890e096a6fc54e8a","*   The company has granted **23,46,452 stock options** to eligible employees under its \"Employee Stock Option Scheme - X\".\n*   This action was approved by the Nomination and Remuneration Committee on April 29, 2026.\n*   The grant represents a **potential future equity dilution** for existing shareholders upon vesting and exercise.\n*   Details such as the exercise price and vesting period were not disclosed in this filing.",{"company_name":579,"filing_date":580,"filing_source":9,"headline":581,"id":582,"stock_code":583,"summary_text":584},"Parle Industries Ltd","2026-04-29T20:01:41.210000","Corporate Restructuring: GVTPL No Longer a Subsidiary","69f216960c6b4fb98a91ecd2","532911","*   Golden-Valley Treasure Park Pvt. Ltd. (GVTPL) has ceased to be a subsidiary of Parle Industries Ltd, effective March 31, 2026.\n*   The change occurred due to a dilution of Parle's shareholding after GVTPL issued new shares to strategic investors.\n*   GVTPL is now reclassified as an \"Associate company\".\n*   This will impact the company's consolidated financial statements, as the investment will now be accounted for using the equity method.",{"company_name":586,"filing_date":587,"filing_source":9,"headline":588,"id":589,"stock_code":590,"summary_text":591},"Epuja Spiritech Ltd","2026-04-29T20:01:41.200000","Confirms It Is Not a 'Large Corporate'","69f2167858d874434539ce8d","532092","*   The company has filed a declaration confirming it does not meet the criteria to be classified as a \"Large Corporate\" under SEBI regulations.\n*   This exempts it from the mandatory requirement to raise a minimum of 25% of its new long-term borrowings through debt securities.\n*   The filing also highlighted a recent name change from \"Sagar Productions Limited,\" a significant event for investors to note.",{"company_name":593,"filing_date":594,"filing_source":9,"headline":595,"id":596,"stock_code":597,"summary_text":598},"Samvardhana Motherson International Ltd","2026-04-29T19:56:41.606000","Debt Jumps 81% as Company Confirms Large Corporate Status","69f2157858d874434539ce86","MOTHERSON","*   The company has confirmed its status as a \"Large Corporate\" under SEBI regulations, a requirement for raising funds through debt securities for the FY ended March 31, 2026.\n*   Total outstanding borrowings surged by 81.36% year-over-year, reaching ₹5,740 Crore as of March 31, 2026, up from ₹3,165 Crore the previous year.\n*   Despite the significant increase in leverage, the company maintains the highest possible credit ratings (CRISIL AAA, IND AAA, ICRA AAA), indicating a very strong credit profile.",{"company_name":600,"filing_date":601,"filing_source":9,"headline":602,"id":603,"stock_code":604,"summary_text":605},"Bansisons Tea Industries Ltd","2026-04-29T19:56:41.542000","Board Meeting to Approve Annual Results Postponed Last-Minute","69f215aebf8f716f13ff6ca7","519353","*   The Board of Directors meeting scheduled for April 29, 2026, to approve annual financial results has been postponed on the day of the meeting.\n*   The meeting has been rescheduled to **Saturday, May 2, 2026**.\n*   This last-minute delay is a **potential red flag** that could suggest issues in finalizing accounts or unresolved auditor queries.\n*   The company has recently changed its name to **Novyra Pharmachem Limited**, indicating a major strategic pivot from the tea industry to the pharmaceutical\u002Fchemical sector.",{"company_name":607,"filing_date":608,"filing_source":9,"headline":609,"id":610,"stock_code":611,"summary_text":612},"Mitshi India Ltd","2026-04-29T19:56:41.386000","Compliance Update: Not a 'Large Corporate'","69f215a80c6b4fb98a91eccc","523782","• The company has filed a declaration confirming it does not qualify as a \"Large Corporate\" under SEBI regulations (Circular dated 26th Nov 2018).\n• As a result, Mitshi India is not mandated to raise a specified portion of its long-term borrowings through debt securities (bonds).\n• This provides the company with greater flexibility in its financing strategy.\n• The declaration indicates the company's scale is below the SEBI threshold, which requires outstanding long-term borrowings of ₹100 Crore and above.",{"company_name":614,"filing_date":615,"filing_source":9,"headline":616,"id":617,"stock_code":618,"summary_text":619},"Garware Hi-Tech Films Ltd","2026-04-29T19:56:41.337000","Confirms Zero Debt Status, Not a Large Corporate","69f2155c5236ec998939cb12","GRWRHITECH","*   The company has formally confirmed it does not meet the criteria to be classified as a \"Large Corporate\" for the financial year 2026-27.\n*   This is because the company reported **NIL outstanding borrowings** as of March 31, 2026, making it a debt-free entity.\n*   Despite having no debt, it holds a high credit rating of 'CARE AA-', indicating a strong financial position and very low credit risk.\n*   Consequently, the company is not obligated to raise a mandatory portion of its borrowings through debt securities.",true,100,3,1847]